BURLINGAME, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment platform based on Nano-Pulse Electro-Signaling (NPES™), announced today it will host an investor conference call on September 7, 2016, at 4:30 p.m. EDT / 1:30 p.m. PDT. The company will highlight progress to date and provide an overview of corporate strategies, financials, and future milestones.
